Recipharm will manufacture solid dose products for Roche

| By | | News

Recipharm, a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry, announced that it has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products.

Recipharm will also acquire a manufacturing facility currently employing approximately 200 people located in Leganés, Spain, from Roche. The modern, well-equipped factory, located close to Madrid, currently produces solid dose products and is licensed to supply products globally to more than 95 countries.

”We are continuing to gain momentum in the CDMO market through our various profitable growth initiatives,” said Thomas Eldered, CEO Recipharm AB. “I am therefore delighted to announce this long-term agreement with Roche. It has become clear during our interactions with Roche that we are closely aligned in our ways of doing business, and we look forward to developing this relationship further by providing high-quality, reliable supplies from Leganés in future. In addition, we see a highly interesting business development opportunity to add new customers.”

SOURCE: recipharm
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.